Compare CSTL & ALNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSTL | ALNT |
|---|---|---|
| Founded | 2007 | 1962 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 944.3M |
| IPO Year | 2019 | N/A |
| Metric | CSTL | ALNT |
|---|---|---|
| Price | $40.31 | $61.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $46.00 | ★ $50.33 |
| AVG Volume (30 Days) | ★ 331.6K | 142.6K |
| Earning Date | 02-26-2026 | 03-04-2026 |
| Dividend Yield | N/A | ★ 0.20% |
| EPS Growth | N/A | ★ 28.52 |
| EPS | N/A | ★ 1.12 |
| Revenue | $343,530,000.00 | ★ $533,134,000.00 |
| Revenue This Year | $2.54 | $4.80 |
| Revenue Next Year | N/A | $5.42 |
| P/E Ratio | ★ N/A | $54.65 |
| Revenue Growth | ★ 10.15 | N/A |
| 52 Week Low | $14.59 | $19.25 |
| 52 Week High | $42.18 | $62.88 |
| Indicator | CSTL | ALNT |
|---|---|---|
| Relative Strength Index (RSI) | 57.91 | 65.29 |
| Support Level | $38.73 | $59.78 |
| Resistance Level | $41.60 | $62.70 |
| Average True Range (ATR) | 1.58 | 2.44 |
| MACD | -0.12 | 0.49 |
| Stochastic Oscillator | 62.75 | 83.10 |
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
Allient Inc, formerly Allied Motion Technologies Inc designs, manufactures, and sells precision and specialty motion control components and systems. The firm primarily caters to the vehicle, medical, aerospace and defense, and electronics and industrial, pumps, and robotics sectors. It mainly operates and sells across the United States, Canada, South America, Europe, and Asia. Its products and solutions include nano precision positioning systems, servo control systems, motion controllers, digital servo amplifiers and drives, brushless servo, torque, and coreless motors, brush motors, integrated motor drives, gear motors, gearing, incremental and absolute optical encoders, active (electronic) and passive (magnetic) filters for power quality and harmonic issues.